Filed: 8/14/2023ACC: 0001123292-23-000094
📋 What this filing means
ATHYRIUM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $154.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$154.15M
Total AUM (reported)
213.57M
Total Shares
Allocation by class
NOTE 7.250% 12/0$60.48M39.2%
NOTE 5.250% 2/1$52.76M34.2%
COM$12.85M8.3%
NOTE 6.250%11/1$11.04M7.2%
NOTE 4.750% 5/0$8.85M5.7%
SHS$8.18M5.3%
Portfolio Concentration
Top 3$124.27M80.6%
4–10$29.88M19.4%
Top 3 weight
80.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 213.57M
Sole
Full voting authority
18.09M
shares
% of voting shares8.5%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
195.48M
shares
% of voting shares91.5%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeNone · 91.5% of voting shares
Institutional Holdings7
Rows:
Biora Inc.
SOLEShares103.50M
TypePRN
Market value$60.48M
39.23%
Sole
0.00
Shared
0.00
None
103.50M
Omeros Corp
SOLEShares71.98M
TypePRN
Market value$52.76M
34.22%
Sole
0.00
Shared
0.00
None
71.98M
Omeros Corp
SOLEShares11.01M
TypePRN
Market value$11.04M
7.16%
Sole
0.00
Shared
0.00
None
11.01M
Paratek Pharmaceuticals Inc.
SOLEShares9M
TypePRN
Market value$8.85M
5.74%
Sole
0.00
Shared
0.00
None
9M
RVL PHARMACEUTICALS PLC
SOLEShares14.60M
TypeSH
Market value$8.18M
5.31%
Sole
14.60M
Shared
0.00
None
0.00
Biora Inc.
SOLEShares1.69M
TypeSH
Market value$6.52M
4.23%
Sole
1.69M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares1.79M
TypeSH
Market value$6.33M
4.10%
Sole
1.79M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Biora Inc.SOLE | Note 7.250% 12/0 | 103.50M | PRN | $60.48M 39.23% | 0.00 | 0.00 | 103.50M |
Omeros CorpSOLE | NOTE 5.250% 2/1 | 71.98M | PRN | $52.76M 34.22% | 0.00 | 0.00 | 71.98M |
Omeros CorpSOLE | NOTE 6.250%11/1 | 11.01M | PRN | $11.04M 7.16% | 0.00 | 0.00 | 11.01M |
Paratek Pharmaceuticals Inc.SOLE | NOTE 4.750% 5/0 | 9M | PRN | $8.85M 5.74% | 0.00 | 0.00 | 9M |
RVL PHARMACEUTICALS PLCSOLE | SHS | 14.60M | SH | $8.18M 5.31% | 14.60M | 0.00 | 0.00 |
Biora Inc.SOLE | COM | 1.69M | SH | $6.52M 4.23% | 1.69M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 1.79M | SH | $6.33M 4.10% | 1.79M | 0.00 | 0.00 |